Latest filing published 10 May 2022 for Candel Therapeutics, Inc., €237k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Laura K. Aguilar: trading record in brief
Laura K. Aguilar, listed as senior executive, appears in our data through filings on Candel Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 29 July 2021 and the latest from 6 May 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 10 May 2022, reports a share grant of €237k in Candel Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Laura K. Aguilar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 171,335 shares@ US$1.46100.0% of flowCommon StockSEC:0000899243-22-017477:0
- 56,096 sharesCommon StockSEC:0000899243-21-031088:0
2 of 2 declarations
